Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kidney Histopathological Features in Patients After COVID-19 and SARS-CoV-2 Vaccination

NCT05043168 is registered in ClinicalTrials.gov with University of Giessen as lead sponsor.

NCT NCT05043168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05043168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kidney Histopathological Features in Patients After COVID-19 and SARS-CoV-2 Vaccination
Lead sponsor
University of Giessen
Phase
Observational
Overall status
Completed
Start date
September 18, 2021
Completion date
May 17, 2022
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, vaccination reaction